TY - JOUR
AU - K Mahaffey
BT - Diabetes, Obesity and Metabolism
PY - 2020
SP - 46 
EP -  54
T2 - Diabetes, Obesity and Metabolism
TI - Dedicated kidney disease-focused outcome trials with sodium-glucose cotransporter-2 inhibitors: Lessons from CREDENCE and expectations from DAPA-HF, DAPA-CKD, and EMPA-KIDNEY
VL - 22
ER -